Abstract
Cardiac regenerative medicine is an emerging field that aims to revolutionize the treatment of heart disease through innovative therapies and technologies. This review highlights the key advancements in human induced pluripotent stem cell (hiPSC) therapy that are paving the way for novel approaches to repair and regenerate damaged cardiac tissue. Substantial progress has been made over the past decade, laying a strong foundation for future developments. However, to fully realize the potential of hiPSC-based therapies, it is crucial to address challenges related to safety, scalability, and ethical considerations. As the field evolves, cardiac regenerative medicine promises to transform cardiovascular care by providing more effective, personalized, and sustainable treatments, ultimately improving patient outcomes and quality of life. This review offers a comprehensive overview of the current state and prospects of regenerative therapies for heart disease, emphasizing the opportunities and challenges in this rapidly advancing field.
| Original language | English |
|---|---|
| Journal | Journal of cardiology |
| DOIs | |
| Publication status | Accepted/In press - 2026 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Cardiac regeneration: The present state and future direction of human pluripotent stem cell therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver